Multicenter Phase 1b/2 Study of Tivozanib in Patients With Advanced Inoperable Hepatocellular Carcinoma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Tivozanib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 19 Jan 2018 According to an AVEO Oncology media release, data were presented at the 2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.
- 10 Jun 2017 Biomarkers information updated
- 22 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 14 Aug 2017.